Sunshine Act Meeting, 22147 [2011-9682]

Download as PDF Federal Register / Vol. 76, No. 76 / Wednesday, April 20, 2011 / Notices No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Lin Zhi International Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Lin Zhi International Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 13, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–9611 Filed 4–19–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Registration By Notice dated August 2, 2010, and published in the Federal Register on September 1, 2010, (75 FR 53721), Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: srobinson on DSKHWCL6B1PROD with NOTICES Drug Schedule 4–Methoxyamphetamine (7411) ... Dihydromorphine (9145) ............... Amphetamine (1100) .................... Methamphetamine (1105) ............ Lisdexamfetamine (1205) ............. Methylphenidate (1724) ................ Pentobarbital (2270) ..................... Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Meperidine (9230) ........................ Methadone (9250) ........................ Methadone intermediate (9254) ... Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... VerDate Mar<15>2010 17:52 Apr 19, 2011 I I II II II II II II II II II II II II II II II II Jkt 223001 Drug Schedule Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Alfentanil (9737) ........................... Reminfentanil (9739) .................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chattem Chemicals Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Chattem Chemicals Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 13, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–9620 Filed 4–19–11; 8:45 am] BILLING CODE 4410–09–P FOREIGN CLAIMS SETTLEMENT COMMISSION [F.C.S.C. Meeting Notice No. 2–11] Sunshine Act Meeting The Foreign Claims Settlement Commission, pursuant to its regulations (45 CFR part 504) and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice in regard to the scheduling of meetings for the transaction of Commission business and other matters specified, as follows: Date and Time: Tuesday, May 10, 2011, at 10 a.m. Subject Matter: Issuance of Proposed Decisions in claims against Albania and Libya. Status: Open. All meetings are held at the Foreign Claims Settlement Commission, 600 E Street, NW., Washington, DC. Requests for information, or advance notices of intention to observe an open meeting, PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 22147 may be directed to: Executive Officer, Foreign Claims Settlement Commission, 600 E Street, NW., Room 6002, Washington, DC 20579. Telephone: (202) 616–6975. Judith H. Lock, Executive Officer. [FR Doc. 2011–9682 Filed 4–18–11; 4:15 pm] BILLING CODE 6770–01–P DEPARTMENT OF LABOR Employment & Training Administration [SGA–DFA–PY–10–03] Solicitation for Grant Applications (SGA); Trade Adjustment Assistance Community College and Career Training Grants Program; Amendment Three Employment and Training Administration (ETA), Labor. ACTION: Notice: Amendment to SGA/ DFA PY 10–03. AGENCY: The Employment and Training Administration published a notice in the Federal Register on January 21, 2011, announcing the availability of funds and Solicitation for Grant Applications (SGA) for the Trade Adjustment Assistance Community College and Career Training grant program (TAACCCT) to be awarded through a competitive process. This amendment to the SGA clarifies items related to making portions of grant applications publicly available. The document is hereby amended. In Section IIIG3, of the solicitation (http://www.doleta.gov/grants/pdf/ SGA–DFA–PY–10–03.pdf), the following text should be replaced: Old Text—‘‘The Department is committed to conducting a transparent grant award process and publicizing information about program outcomes. Applicants are advised their application and information related to its review and evaluation (whether or not the application is successful) may be made publicly available, either fully or partially. In addition, information about grant progress and results may also be made publicly available.’’ New Text—‘‘The Department is committed to conducting a transparent grant application and award process. Among other things, posting grant applications on public Web sites is a means of promoting and sharing innovative ideas. For this grant competition, we will publish the Technical Proposal required by Section IVB, Part II for all those applications that are awarded grants, on the SUMMARY: E:\FR\FM\20APN1.SGM 20APN1

Agencies

[Federal Register Volume 76, Number 76 (Wednesday, April 20, 2011)]
[Notices]
[Page 22147]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9682]


=======================================================================
-----------------------------------------------------------------------

FOREIGN CLAIMS SETTLEMENT COMMISSION

[F.C.S.C. Meeting Notice No. 2-11]


Sunshine Act Meeting

    The Foreign Claims Settlement Commission, pursuant to its 
regulations (45 CFR part 504) and the Government in the Sunshine Act (5 
U.S.C. 552b), hereby gives notice in regard to the scheduling of 
meetings for the transaction of Commission business and other matters 
specified, as follows:
    Date and Time: Tuesday, May 10, 2011, at 10 a.m.
    Subject Matter: Issuance of Proposed Decisions in claims against 
Albania and Libya.
    Status: Open.
    All meetings are held at the Foreign Claims Settlement Commission, 
600 E Street, NW., Washington, DC. Requests for information, or advance 
notices of intention to observe an open meeting, may be directed to: 
Executive Officer, Foreign Claims Settlement Commission, 600 E Street, 
NW., Room 6002, Washington, DC 20579. Telephone: (202) 616-6975.

Judith H. Lock,
Executive Officer.
[FR Doc. 2011-9682 Filed 4-18-11; 4:15 pm]
BILLING CODE 6770-01-P